• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Obstetrics

Co-occurring substance use disorders are common in pregnant women

byNancy LuandAvneesh Bhangu
December 24, 2021
in Obstetrics, Wellness
Reading Time: 2 mins read
2 Minute Rewind November 29, 2021
Share on FacebookShare on Twitter

1. Approximately 7% of pregnant women were diagnosed with at least one substance use disorder at delivery.

2. Many patients had co-occurring substance use disorders, the most common of which was tobacco and cannabis use disorders.

Evidence Rating Level: 2 (Good)

 In the past decade, research has demonstrated an increase in substance use in pregnancy, including opioid, amphetamine, and cannabis use. Each of these substances are associated with adverse fetal outcomes, including growth restriction and preterm birth. Multiple substance use disorders (SUDs) may exacerbate this issue. Thus, it is important to understand the prevalence of polysubstance abuse amongst pregnant women.

This study was a nationally representative stratified sample from the National Inpatient Sample (NIS) administered by the United States (US) Agency of Healthcare Research and Quality. Participants were included if they were aged 15-44 and had a hospital delivery between 2007 and 2016 (weighted N=38 million). Patients were excluded if they did not have a delivery hospitalization. Information about substance use disorders was collected through the diagnosis codes recorded from NIS.

This study showed that overall, 7.3% of women were diagnosed with at least one SUD, including tobacco, cannabis, opioid, amphetamine, alcohol, sedative, or cocaine. Co-occurring SUDs were also common, the most common combination being tobacco and cannabis. Those who used sedatives had an 83.7% chance of using at least one other substance. This study was limited in its use of diagnosis codes to categorize SUD (which likely underestimated the true prevalence of SUDs). Furthermore, there was limited information to differentiate whether these substances were prescribed and misused versus illicit substance use. Despite these limitations, this study encourages further study on the effect of multiple substances on pregnancy outcomes.

RELATED REPORTS

Deficits in executive function are not universal among patients with alcohol use disorder

Few interventions improve posthospitalization follow-up for alcohol use disorder

Behavioral support does not improve patient-directed opioid tapering success

Click to read the study in Journal of Addiction Medicine

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Alcoholcannabisdrugopioidpregnancypregnantsedativesubstance use disorder
Previous Post

Severe gastrointestinal involvement in children with SARS-CoV-2 infection and multisystem inflammatory syndrome

Next Post

Only one quarter of benzodiazepine prescriptions in youth are for approved indication

RelatedReports

Chronic Disease

Deficits in executive function are not universal among patients with alcohol use disorder

September 15, 2026
Chronic Disease

Few interventions improve posthospitalization follow-up for alcohol use disorder

September 14, 2026
Chronic Disease

Behavioral support does not improve patient-directed opioid tapering success

July 6, 2026
Systematic review examines benefits and adverse effects of cannabinoid therapy
Emergency

Combined use of cannabis and alcohol may increase driving impairment and subjective intoxication

May 8, 2026
Next Post
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial

Only one quarter of benzodiazepine prescriptions in youth are for approved indication

Compliance-linked incentives increase infant immunizations rates in rural India

No Difference in Antibody or Humoral Responses Among Kidney Transplant Recipients Vaccinated with a 3rd Dose of mRNA or Adenovirus Vector Vaccine

Type 2 diabetes associated with reduction in disability-free life years

2 Minute Medicine Rewind December 27, 2021

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.